The midrange left ventricular ejection fraction (LVEF) is associated with higher all-cause mortality during the 1-year follow-up compared to preserved LVEF among real-world patients with acute heart failure: a single-center propensity score-matched analysis

Heart and Vessels
Josip Anđelo BorovacDuska Glavas

Abstract

The objectives of the study were to characterize and compare different acute heart failure (AHF) subgroups according to left-ventricular ejection fraction (LVEF) in terms of all-cause mortality and HF-related readmissions during the 1-year follow-up (FU). Three hundred and fifty-six AHF patients admitted to Cardiology ward and/or CCU were retrospectively included in the study and analyzed during the 1-year FU. Patients were stratified according to LVEF as those with preserved (HFpEF), midrange (HFmrEF) and reduced LVEF (HFrEF). During the FU period, 148 (43.3%) patients died, and 116 HF-related readmission events were recorded. HFmrEF group had significantly higher standardized all-cause mortality rate, unadjusted for age, compared to HFpEF group and significantly lower than HFrEF group (41 vs. 18 and 41 vs. 62.5 events per 100 patient-years; χ2 = 41.08, p < 0.001 and χ2 = 16.62, p < 0.001, respectively). A propensity score-matched analysis in which all HF groups were matched for age and other covariates confirmed that HFmrEF group had significantly higher all-cause mortality rate than HFpEF group (χ2 = 15.66, p < 0.001) while no significant differences in readmission rates were observed across all groups (p = NS). The hazard r...Continue Reading

References

Nov 20, 2003·JAMA : the Journal of the American Medical Association·Douglas S LeeJack V Tu
Dec 21, 2005·Circulation·Mihai GheorghiadeUNKNOWN International Working Group on Acute Heart Failure Syndromes
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Mar 27, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Andrew S Levey, Lesley A Stevens
Jun 12, 2013·Journal of the American College of Cardiology·Clyde W YancyUNKNOWN American Heart Association Task Force on Practice Guidelines
Sep 12, 2014·European Journal of Heart Failure·Carolyn S P Lam, Scott D Solomon
Jun 22, 2016·European Journal of Heart Failure·Maria G Crespo-LeiroUNKNOWN Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Jul 30, 2016·Journal of Cardiac Failure·Lars H Lund
Aug 31, 2016·Nature Reviews. Nephrology·Joerg C SchefoldStephan von Haehling
Sep 18, 2016·Journal of Intensive Care Medicine·Drayton A HammondApril Miller Quidley
Dec 22, 2016·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Dimitrios FarmakisJohn Parissis
Apr 4, 2017·European Journal of Heart Failure·Kanako TsujiUNKNOWN CHART-2 Investigators
Aug 9, 2017·Current Heart Failure Reports·Sameer Kurmani, Iain Squire
Sep 28, 2017·European Journal of Heart Failure·Angela S KohLars H Lund
Oct 19, 2017·European Heart Journal·John G F ClelandUNKNOWN Beta-blockers in Heart Failure Collaborative Group
Dec 12, 2017·European Journal of Heart Failure·Vijeta BhambhaniJennifer E Ho
Jan 16, 2018·European Journal of Heart Failure·Lars H LundGianluigi Savarese
Feb 24, 2018·Trends in Cardiovascular Medicine·Andrew XanthopoulosRandall C Starling

❮ Previous
Next ❯

Related Concepts

Related Feeds

Argentine Hemorrhagic Fever

Argentine hemorrhagic fever (AHF) is an endemo-epidemic disease caused by junín virus (JUNV), a member of the arenaviridae family. Discover the latest research on AHF here.